Authors: Illingworth, RD Crouse, JR Hunninghake, DB Davidson, MH Escobar, ID Stalenhoef, AFH Paragh, G Ma, PTS Liu, M Melino, MR O'Grady, L Mercuri, M Mitchel, YB

Citation: Rd. Illingworth et al., A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial, CURR MED R, 17(1), 2001, pp. 43-50

Authors: Davidson, MH Stein, EA Hunninghake, DB Ose, L Dujovne, CA Insull, W Bertolami, M Weiss, SR Kastelein, JJP Scott, RS Campodonico, S Escobar, ID Schrott, HG Bays, H Stepanavage, ME Wu, M Tate, AC Melino, MR Kush, D Mercuri, M Mitchel, YB

Citation: Mh. Davidson et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia, NUTR MET CA, 10(5), 2000, pp. 253-262

Authors: Ose, L Davidson, MH Stein, EA Kastelein, JJP Scott, RS Hunninghake, DB Campodonico, S Insull, W Escobar, ID Schrott, HG Stepanavage, ME Wu, M Tate, AC Melino, MR Mercuri, M Mitchel, YB

Citation: L. Ose et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Long-term experience in a large group of patients with hypercholesterolemia, CLIN CARD, 23(1), 2000, pp. 39-46

Authors: Kastelein, JJP Isaacsohn, JL Ose, L Hunninghake, DB Frohlich, J Davidson, MH Habib, R Dujovne, CA Crouse, JR Liu, MZ Melino, MR O'Grady, L Mercuri, M Mitchel, YB

Citation: Jjp. Kastelein et al., Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels, AM J CARD, 86(2), 2000, pp. 221-223